About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Runx1tm2.1(cre/Esr1*)Ims
targeted mutation 2.1, Igor M Samokhvalov
MGI:5316015
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Runx1tm2.1(cre/Esr1*)Ims/Runx1tm2.1(cre/Esr1*)Ims involves: C57BL/6 MGI:5316039
cn2
Runx1tm2.1(cre/Esr1*)Ims/Runx1tm1Medv involves: 129P2/OlaHsd * C57BL/6 MGI:5316037
cn3
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Runx1tm2.1(cre/Esr1*)Ims/Runx1tm1Medv
B6.Cg-Gt(ROSA)26Sortm1(EYFP)Cos Runx1tm2.1(cre/Esr1*)Ims MGI:5316038


Genotype
MGI:5316039
hm1
Allelic
Composition
Runx1tm2.1(cre/Esr1*)Ims/Runx1tm2.1(cre/Esr1*)Ims
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Runx1tm2.1(cre/Esr1*)Ims mutation (0 available); any Runx1 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

hematopoietic system
• embryos exhibit severe liver anemia

cardiovascular system
• embryos display a severe hemorrhagic phenotype




Genotype
MGI:5316037
cn2
Allelic
Composition
Runx1tm2.1(cre/Esr1*)Ims/Runx1tm1Medv
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Runx1tm1Medv mutation (0 available); any Runx1 mutation (34 available)
Runx1tm2.1(cre/Esr1*)Ims mutation (0 available); any Runx1 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• maternal injection of 200-250 mg of 4-hydroxytamoxifen (4-OHT) on E6.5 or E7.5 rescues prenatal lethality, but pups, although born apparently normal, are unable to feed and die within 1 day of birth
• all embryos die around E12.5
• maternal injection of 5-6 mg of 4-hydroxytamoxifen (4-OHT) on E6.5 or E7.5 to reactivate the Runx1lacZ allele rescues 90-100% of the E12.5 lethality; similarly, a low dose of tamoxifen (2 mg) at E7.5 also results in robust (80-100%) rescue of lethality assayed at E16.5 or P0
• reactivation of the Runx1lacZ allele with maternal tamoxifen treatment at E8.0, 8.5, 9.0, or 9.5 does not rescue the hemorrhagic or liver anemia phenotypes; pregastrulation tamoxifen injection at E5.5 does not result in embryo rescue

hematopoietic system
N
• with maternal injection of high-dose tamoxifen on E7.5 to induce Runx1 reactivation, restoration of definitive hematopoiesis is observed by E16.5; FACS analyses of blood cell populations are similar to control heterozygous cells
• tamoxifen treatment at times after E7.5 results in no rescue of definitive hematopoietic progenitor cells; only a few progenitors can be observed with tamoxifen treatment at E8.5 with none found with later treatment timepoints
• embryos exhibit severe liver anemia

cardiovascular system
• embryos display a severe hemorrhagic phenotype




Genotype
MGI:5316038
cn3
Allelic
Composition
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Runx1tm2.1(cre/Esr1*)Ims/Runx1tm1Medv
Genetic
Background
B6.Cg-Gt(ROSA)26Sortm1(EYFP)Cos Runx1tm2.1(cre/Esr1*)Ims
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(EYFP)Cos mutation (11 available); any Gt(ROSA)26Sor mutation (992 available)
Runx1tm1Medv mutation (0 available); any Runx1 mutation (34 available)
Runx1tm2.1(cre/Esr1*)Ims mutation (0 available); any Runx1 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
N
• with maternal injection of high-dose tamoxifen on E7.5 to induce Runx1 reactivation, trasnsplanted, hematopoietic stem cells were isolated and injected into irradiated recipients for a long-term competitive repopulation assay; at E14.5 and E16.5, no signficant differences in reconstitution levels of hematopoietic cells is observed relative to controls
• secondary transplantation of yolk sac-derived bone marrow cells from the primary recipients 12 months following primary transplantation resulted in long-term engraftment
• exposure of embryos to tamoxifen at E10.5 fails to result in observation of CD45+ definitive hematopoietic cells in the aorta-gonad-mesonephros (AGM) region (no rescue of definitive hematopoiesis), whereas after exposure to tamoxifen at E7.5, a large population of CD45-positive cells are detected





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory